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Abstract
This paper proposes the integration and analysis of a closed-loop model of the
baroreflex and cardiovascular systems, focused on a time-varying estimation of
the autonomic modulation of heart rate in Brugada syndrome (BS), during ex-
ercise and subsequent recovery. Patient-specific models of 44 BS patients at
different levels of risk (symptomatic and asymptomatic) were identified through
a recursive evolutionary algorithm. After parameter identification, a close match
between experimental and simulated signals (mean error = 0.81%) was observed.
The model-based estimation of vagal and sympathetic contributions were consis-
tent with physiological knowledge, enabling to observe the expected autonomic
changes induced by exercise testing. In particular, symptomatic patients pre-
sented a significantly higher parasympathetic activity during exercise, and an
autonomic imbalance was observed in these patients at peak effort and during
post-exercise recovery. A higher vagal modulation during exercise, as well as
an increased parasympathetic activity at peak effort and a decreased vagal con-
tribution during post-exercise recovery could be related with symptoms and,
thus, with a worse prognosis in BS. This work proposes the first evaluation of
the sympathetic and parasympathetic responses to exercise testing in patients
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suffering from BS, through the recursive identification of computational models;
highlighting important trends of clinical relevance that provide new insights into
the underlying autonomic mechanisms regulating the cardiovascular system in
BS.
Keywords: Autonomic nervous system, Brugada syndrome, computational
model, recursive identification
1. Introduction
Brugada syndrome (BS) is an inherited disorder presenting a distinctive
electrocardiographic pattern associated with an elevated risk for sudden cardiac
death (SCD) [1]. Major cardiac events in this population typically occur at
rest and mainly at night, suggesting that the autonomic nervous system (ANS)5
function, and more specifically the parasympathetic activity, may play a relevant
role in the pathophysiology, arrhythmogenesis and prognosis of the disease [2,
3, 4].
However, previous studies on the ANS function of BS patients have led to
conflicting results, particularly when based on long-term measurements. Krit-10
tayapong et al. concluded that BS patients showed a decreased heart rate
variability (HRV) and vagal tone at night compared to controls; as well as a
lower diurnal and higher overnight heart rate (HR) when symptomatic patients
were compared to asymptomatic subjects and controls [5]. Likewise, Hermida
et al. found significantly lower HRV values at night on symptomatic patients15
[6]; and Pierre et al. observed a decreased HRV in BS patients, with respect
to healthy subjects [7]. Results from Tokuyama et al. also showed a signifi-
cant HRV reduction on BS patients with respect to controls, as well as on both
sympathetic and parasympathetic tones and on their circadian variation over
24 hours [8].20
In a previous study from our team [9], although symptomatic BS patients
showed a decreased heart rate variability and complexity at night, with re-
spect to asymptomatic subjects, no significant differences were observed be-
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tween groups on sympathetic and parasympathetic modulations. On the other
hand, in Nakazawa et al., results showed higher vagal and reduced sympathetic25
tones in symptomatic BS patients [10]. Likewise, in a recent work from Be-
har et al., symptomatic subjects showed an increased parasympathetic activity
during both daytime and nighttime, when compared to asymptomatic patients
[11]. Finally, HRV analysis in Kostopoulou et al. did not reveal any significant
difference between BS patients and controls [12].30
Thus, in order to better characterize autonomic modulation, standard ma-
neuvers such as exercise testing can be applied. Exertion causes a sympathetic
activation that, together with a parasympathetic inhibition, increases HR, a
reliable indicator to evaluate cardiac autonomic function [13]. Conversely, post-
exercise cardiodeceleration is adjusted by parasympathetic activation and sym-35
pathetic withdrawal [14]. Indeed, some studies have already reported the po-
tential of exercise testing in BS [15, 16, 17, 18]. Amin et al. [19] found a higher
parasympathetic reactivation during early recovery after exertion in BS patients
with prior ventricular fibrillation events. Likewise, Makimoto et al. concluded
that a higher vagal activity after exercise was related to the occurrence of cardiac40
events in BS [20].
Although classical temporal and spectral markers are widely used in clini-
cal practice for ANS analysis [21], conventional methods have failed to estimate
sympathetic and parasympathetic responses to exercise, even in healthy subjects
[22], but also in Brugada syndrome patients [18, 23]. Nevertheless, since compu-45
tational models can directly represent interactions between the cardiovascular
system (CVS) and the ANS, model-based reasoning could provide useful knowl-
edge to support autonomic response interpretation in BS. Indeed, in a previous
work, we already reported the feasibility of the application of such computa-
tional models to reproduce cardiovascular data acquired during head-up tilt50
testing on a healthy subject and on a BS patient [24]. However, the identifi-
cation method applied to the system-level models used in this work could only
explain the mechanical, circulatory and autonomic sympathetic functions of the
cardiovascular system. To tackle this limitation, high-frequency oscillations in-
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duced by the parasympathetic regulation of the ANS can be estimated through55
recursive identification.
Therefore, in this work we propose a novel approach based on the recur-
sive identification of a closed-loop mathematical model of the baroreflex and
cardiovascular systems, in order to estimate the time-varying sympathetic and
parasympathetic contributions to HR modulation during exercise and subse-60
quent recovery on Brugada patients. Patient-specific models were adjusted for
44 BS patients with different levels of risk (13 symptomatic and 31 asymp-
tomatic) so as to reproduce their HR during exercise testing and, thus, ana-
lyze their underlying autonomic function. The paper is organized as follows:
in section 2, the experimental protocol and data under study are presented,65
the computational model is described and the recursive identification method
is explained. In section 3, the results of applying the described methods are
presented and discussed. Conclusions are finally specified in section 4.
2. Material and Methods
2.1. Study population70
The standard 12-lead ECG recordings from 44 patients diagnosed with BS
who took part in a physical stress test were collected during a multicentric
study conducted in the Cardiology department of the Rennes University Hospi-
tal (France). Participants were enrolled in 6 French hospitals located in Rennes,
Saint Pierre de la Reunion, Nantes, Bordeaux, Brest and La Rochelle. The study75
protocol was approved by the respective local ethics committees and all patients
provided written informed consent before participation.
In accordance with current guidelines [25], BS was diagnosed when a coved
ST-segment elevation (≥ 0.2 mV) was identified in at least one right precordial
lead (V1 and/or V2) located in the 2nd, 3rd or 4th intercostal space, in the80
presence or absence of sodium-channel-blocking agent.
In order to characterize populations with different levels of risk, patients
were classified as symptomatic or asymptomatic, based on their medical his-
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tory. Thirteen patients presented documented symptoms of ventricular origin:
syncope (61.5%), cardiac arrest (38.5%) and dizziness (15.4%), whereas the re-85
maining 31 patients were considered as asymptomatic.
Patients age ranged from 19 to 74 years old (45.07 ± 12.59 years old) and
33 (75%) were males. ICD implantation had been performed in 6 of 31 (19.4%)
asymptomatic patients, based on a positive EPS test, whereas all symptomatic
patients were ICD carriers. Among 31 patients (11 were symptomatic) in whom90
genetic screening was performed, an SCN5A mutation was found in 13 (41.9%),
from whom 6 were symptomatic.
Table 1 summarizes the clinical characteristics of patients included in the
study. Since all between-groups differences, apart from ICD implantation, were
statistically non-significant, similar baseline characteristics were assumed be-95
tween populations.
Table 1: Clinical characteristics of BS patients.
Symptomatic Asymptomatic p-value
(n=13) (n=31)
Age, years old 43.62 ± 14.51 45.68 ± 11.90 0.322
Male sex, n (%) 11 (84.6%) 22 (71%) 0.355
ICD implantation, n (%) 13 (100%) 6 (19.4%) <0.001
SCN5A mutation, n (%) 6 (46.2%) 5 (25%) 0.311
Values are mean ± standard deviation or number of observations (%).
Comparisons are based on Mann-Whitney U non-parametric tests.
2.2. Experimental protocol and data
Participants underwent a triangular exercise test recommended by the Amer-
ican Heart Association [26], which was performed on a cyclo ergometer (Ergoline
900 Egamed, Piestany, Slovakia) and divided in the following phases, repre-100
sented in Fig. 1:
• Exercise phase:
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– Warm-up phase: for men, initial load of 50 watts (W); for women,
initial load of 30 W, both for 2 minutes.
– Incremental exercise phase: for men, initial load of 80 W for 2 minutes105
and then incrementing 20 W every 2 minutes; for women, initial load
of 50 W, increasing 20 W every 2 minutes. For each patient, the
load was increased until it reached the 80% of his/her theoretical
maximum heart rate, defined by the formula MHR = 220−age [27].
• Recovery phase: for men, fixed load of 50 W; for women, fixed load of 30110
W, both for 3 minutes.
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Figure 1: Representative example of RR-interval series observed during the exercise test. The
test was divided in three phases: warm-up, incremental exercise and recovery. Due to differ-
ences in exercise durations for each patient, recursive identifications were separately performed
at the beginning and at the end of the test (exercise and recovery analysis, respectively). Ex-
ercise analysis included the warm-up phase and the first 3 minutes of incremental exercise;
while recovery analysis was based on the last minute of exertion before peak effort and the
recovery phase.
ECG data were acquired with the Holter monitor (ELA medical, Sorin
Group, Le Plessis Robinson, France) at a sampling frequency of 1000 Hz. From
these signals, RR-interval series were extracted from the lead presenting the
highest signal-to-noise ratio (SNR), by means of a noise-robust wavelet-based115
algorithm for QRS-complex detection and subsequent R-wave peak location [28].
Since the result is a non-uniformly sampled signal, a cubic-spline interpolation
was applied to RR-interval time series, to obtain regularly sampled data at a
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rate of 10 Hz, which was the sample rate chosen for the model.
2.3. Computational model120
Based on our previous works in cardiovascular modeling [29, 30, 31, 24],
the proposed model was composed of two coupled submodels representing the
cardiovascular system (CVS) and the baroreceptors reflex system (BRS), con-
nected through the HR resulting from the BRS submodel and the systemic
arterial pressure coming from the CVS.125
2.3.1. Cardiovascular system
As illustrated in Fig. 2, the hemodynamic effects of exercise testing were
represented by implementing the cardiovascular model defined in [32].
Figure 2: Closed-loop model of the cardiovascular system. E: elastance; R: resistance; P:
pressure; V: volume; sys: systemic; pul: pulmonary; pv: pulmonary vein; pa: pulmonary
artery; pu: pulmonary valve; av: aortic valve; tc: tricuspid valve; mt: mitral valve; ao: aorta;
vc: venae cavae; LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle.
Volumes (V ) from each cardiac chamber are obtained from the integral of
their respective net flows (Qin − Qout). Blood pressure (P ) is then computed130
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from the pressure-volume relationships associated with systole (Pes) and dias-
tole (Ped), and a periodic function (e(t)) drives the transition between these
relationships as follows:
P (V, t) = e(t)Pes(V ) + (1− e(t))Ped(V ) , (1)
Pes(V ) = E · (V − Vd) , (2)
Ped(V ) = P0 · (exp[λ(V − V0)]− 1) , (3)
e(t) = A · exp[−B · ((t− ts)− C)2] . (4)
E refers to the systolic elastance and Vd is the dead volume, respectively135
representing the slope and intercept of the linear pressure-volume relationship
associated with systole. During diastole, this relationship is non-linear and is
described by a gradient (P0), a curvature (λ) and a volume at zero pressure
(V0). Eq. 4 defines the transition between diastolic and systolic dynamics,
modulated by a Gaussian function with amplitude A, width B and center C;140
and ts refers to the cardiac cycle onset, determined by the HR resulting from
the BRS submodel.
Atria were not included in the model since they minimally contribute to
main cardiac trends. However, in order to account for relevant ventricular in-
teractions, ventricles were coupled through the septum, represented as a flexible145
common wall between left and right ventricles. The left ventricle (LV) free wall
volume (VLV f ) and the right ventricle (RV) free wall volume (VRV f ) are defined
as:
VLV f = VLV − Vspt , (5)
VRV f = VRV + Vspt . (6)
where Vspt, VLV and VRV are respectively the septum, LV and RV volumes.
Then, the septum volume results from linking the septum pressure (Pspt) to the150
difference between left and right ventricular pressures:
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Pspt = PLV − PRV , (7)
Pspt = e(t)Espt · (Vspt − Vd,spt) (8)
+(1− e(t))P0,spt(exp[λ(V − V0)]− 1). (9)
Diodes simulate the one-way direction of blood when passing through valves
located at the inlet and exit of ventricles. Pressures on the peripheral circulation
systems are calculated as a linear relationship between their volume and vascular
elastance, following eq. 2. Finally, flows between chambers are obtained from155
the equation Q = ∆PR , where ∆P is the pressure gradient between two chambers
and R accounts for the corresponding vascular resistance connecting them.
2.3.2. Baroreflex model
Sympathetic and parasympathetic efferent responses to arterial blood pres-
sure regulation were modeled based on a widely used approach [33, 34], repre-160
sented in Fig. 3.
Figure 3: Diagram of the baroreflex model for cardiovascular regulation. From the arterial
pressure registered at the systemic circulation (Pao), the baroreflex system controls heart rate
(HR) and other cardiovascular variables (θ), such as ventricular contractility or elastance,
systemic resistance and venous dead volume.
The systemic arterial pressure registered at the CVS submodel was used as
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the input pressure for the baroreflex system which, in turn, modulated the HR
used as input of the CVS submodel, thus defining the closed-loop model.
Baroreceptors dynamical properties are represented by a first-order transfer165
function, whose gain and time constant are KB and TB . Then, cardiovascular
control is represented, in both sympathetic and vagal branches, by a sigmoidal
function and delays DS and DV , respectively. Sympathetic and parasympa-
thetic contributions are modulated by two time-varying variables, ZS and ZV ,
to account for the influence of exogenous phenomena and collect all the variabil-170
ity caused by sources other than blood pressure fluctuations (central modulation,
respiration, etc.).
For chronotropic regulation, each efferent pathway is finally modeled with a
first-order filter, characterized by a gain (KV , KS) and a time constant (TV , TS).
The output HR is the result of adding the contributions of both sympathetic175
(S) and vagal (V ) branches to the intrinsic heart rate (HR0):
HR = HR0 + S − V. (10)
Finally, other sympathetic branches control ventricular contractility (E),
systemic resistance (R) and venous dead volume (V V ) through a first-order
filter characterized by the sympathetic time constant TS and the gain related
to each branch Kθ, where θ ∈ {E,R, V V }. Being θ0 the baseline response and180
∆θ the baroreflex regulation, the output response for each regulated variable is
defined as:
θ = θ0 + ∆θ. (11)
2.4. Recursive identification
All model parameters other than ZS and ZV were fixed based on the litera-
ture [32, 33, 35]. Their values are provided as Supplementary material (Tables185
I and II).
As illustrated in Fig. 4, at each step i of the recursive algorithm, parameters
ZS and ZV were identified on a time interval TI of duration largely inferior to
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Figure 4: Diagram of the recursive identification algorithm and time windows involved. TL:
overlap window; TI : identification window; RR: error function. For visualization purposes,
TL and TI temporal supports were enlarged in this figure and do not illustrate representative
time windows.
the RR-interval series length (TI << TTOT ). At each step, simulated and
experimental signals were compared in order to minimize the error function190
RR(i), defined as:
RR(i) =
(i+1)TL∑
te=iTL
|RRsim(te)−RRexp(te)| +
iTL+TI∑
te=iTL
|RRsim(te)−RRexp(te)|, i ∈ [0, · · · , N ] (12)
where te is the time elapsed since the onset of the identification period, TL
corresponds to the overlap time between each interval and N = bTTOT /TLc
is the number of identification intervals. The time windows involved in the
recursive identification algorithm are also represented in Fig. 4.195
The overlap time duration TL was set equal to the parasympathetic time
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constant (TV ) to capture rapid fluctuations due to vagal response; whereas
interval TI was set as the sympathetic time constant (TS) in order to take into
account the low frequency component causing RR-interval series slow variations.
As in previous works of our team [36, 37], the best set of {ZS , ZV } pa-200
rameters for each patient was identified on each interval i, through an approach
based on evolutionary algorithms [38]. The initial population, or first set of can-
didate optimization solutions, was randomly generated. For the following steps,
assuming limited parameter variations between intervals, the initial population
was set equal to that obtained from the previous interval i − 1. Although this205
approach limits parameter variations, mutation probability was set to pm = 0.2
in order to stimulate the exploration of the entire search space and prevent from
convergence to local minima.
These recursive identifications were separately performed during exercise
and recovery. Since each patient test differed in the incremental exercise phase210
duration and the shortest case in our clinical series lasted less than 5 minutes, as
represented in Fig. 1, for exercise analysis, only the warm-up phase and the first
3 minutes of incremental exertion were identified. Then, for recovery analysis,
the last minute of exertion and the first 3 minutes of recovery, were assessed.
In order to quantify identification performance, the error between simulated215
and experimental RR-interval series for both exercise (Eexercise) and recovery
(Erecovery) phases was expressed in percentage and computed as:
E =
1
n
n∑
i=1
|100 · RRsim(i)−RRexp(i)
RRexp(i)
|, (13)
where n is the number of samples being compared. Due to identification errors
caused by initialization, the first minute of warm-up was removed from exercise
analysis, as well as the first 30 seconds of the last minute of exertion were220
eliminated from recovery analysis.
2.5. Statistical analysis
The identified time-varying sympathetic (S) and parasympathetic (V ) con-
tributions to exercise and subsequent recovery were then compared between
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symptomatic and asymptomatic patients, by Mann-Whitney U non-parametric225
tests. In order to compare the last minute of exertion and recovery, all patients
were synchronized with respect to the peak effort instant.
The autonomic response to exercise testing was also analyzed by fitting linear
regression models to the estimated S and V of each patient, for the last minute
of warm-up, the first, second and third minutes of incremental exercise, the last230
30 seconds of exertion, and the first, second and third minutes of recovery.
3. Results and Discussion
Based on visual inspection and error results (Eexercise = 1.10 ± 0.54%,
Erecovery = 0.52± 0.16%), a satisfactory agreement was observed between sim-
ulated signals and real data, leading to errors always inferior to 3.5%. Fig. 5235
illustrates an example of simulated and experimental RR-interval series dur-
ing the last minute of warm-up and the first 3 minutes of incremental exercise
(E = 1.7%).
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Figure 5: Simulated (orange) and experimental (black) RR-interval series during the last
minute of warm-up and the first 3 minutes of incremental exercise. E = 1.7%. The dashed
vertical line delimits the end of warm-up and subsequent incremental exercise onset.
Fig. 6 shows the mean vagal and sympathetic contributions of the auto-
nomic response to exertion, for symptomatic and asymptomatic patients. In240
both groups, vagal modulation remained low along the whole exercise phase
and decreased as the test progressed. Conversely, sympathetic contribution in-
creased during exercise, and specially after warm-up. Moreover, symptomatic
patients presented significantly higher parasympathetic values around the sec-
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ond minute of incremental exercise, and mainly at the end of warm-up, where245
this group also presented significantly higher sympathetic values.
Figure 6: Mean estimation of vagal (V ) and sympathetic (S) contributions, for symptomatic
(orange) and asymptomatic (black) patients, during exercise. Dashed vertical lines delimit the
end of warm-up and subsequent incremental exercise onset. Pointed boxes indicate those seg-
ments where significant differences between groups (∗p < 0.05) were found. Dashed horizontal
lines represent the standard deviations for each group.
These results are in agreement with those found in the literature, where a
higher vagal modulation has been observed in symptomatic BS patients [11, 10].
Although some significant differences were also found after 1 minute of incre-
mental exercise, the largest and most significant segment was observed at the250
end of warm-up. Moreover, sympathetic activity in this phase was also found
to be higher in symptomatic patients, contrary to tendencies found in previ-
ous publications based on classical spectral markers [8, 10]. Nevertheless, many
studies on cardiac autonomic function based on classic approaches have failed to
represent the sympathetic response to exercise testing, even in healthy subjects255
[22], since the LF component does not provide an index of sympathetic tone but
rather reflects a complex interplay among many factors including the sympa-
thetic and parasympathetic contributions to ANS. Similarly, our previous works
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based on conventional time-frequency methods failed to estimate the autonomic
response to exercise testing in this population [18, 23]. Thus, model-based rea-260
soning may provide better estimations of the sympathetic and parasympathetic
contributions to HR modulation during exercise.
In Fig. 7, the mean vagal and sympathetic contributions during recovery,
for symptomatic and asymptomatic patients, are represented. After the peak
effort, an increase in parasympathetic activity, as well as a decrease in sympa-265
thetic modulation can be observed for both groups. Although no statistically
significant differences related to symptomatic status were found on the vagal
modulation, at the end of the second minute of recovery, symptomatic patients
presented significantly lower sympathetic values. These findings concur with a
previous work where a lower sympathetic activity was reported in symptomatic270
patients [10].
Figure 7: Mean estimation of vagal (V ) and sympathetic (S) contributions, for symptomatic
(orange) and asymptomatic (black) patients, during post-exercise recovery. Dashed vertical
lines delimit the end of exertion and subsequent recovery onset. The pointed box indicates
the segment where significant differences between groups (∗p < 0.05) were found. Dashed
horizontal lines represent the standard deviations for each group.
Finally, the slopes from the adjusted linear regression models were compared
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between symptomatic and asymptomatic populations. Since no statistically
significant results were obtained during exercise analysis, Table 2 summarizes,
for each analyzed period during recovery, the mean ± standard deviation values275
obtained for each group of patients, together with their associated p-values.
Table 2: Mean ± standard deviation slopes for sympathetic and parasympathetic contribu-
tions (in Hz), and associated p-values, from symptomatic and asymptomatic patients, at peak
effort and during different periods of recovery after exertion (*p <0.05). Comparisons are
based on Mann-Whitney U non-parametric tests.
Symptomatic Asymptomatic p-val
(n=13) (n=31)
Peak effort (30 sec)
Sympathetic 0.09 ± 0.30 -0.03 ± 0.25 0.26
Parasympathetic 0.09 ± 0.22 -0.11 ± 0.25 0.03*
Recovery (1st min)
Sympathetic -0.21 ± 0.26 -0.18 ± 0.27 0.72
Parasympathetic 0.15 ± 0.29 0.15 ± 0.25 0.82
Recovery (2nd min)
Sympathetic -0.22 ± 0.22 -0.02 ± 0.35 0.05
Parasympathetic -0.03 ± 0.18 0.16 ± 0.33 0.04*
Recovery (3rd min)
Sympathetic 0.13 ± 0.40 -0.11 ± 0.51 0.12
Parasympathetic 0.26 ± 0.46 -0.01 ± 0.51 0.11
Symptomatic and asymptomatic patients showed significant differences in
vagal modulation, when compared at peak effort and during the second minute
of recovery. Fig. 8 illustrates the mean slope for symptomatic and asymptomatic
populations at peak effort and during recovery, highlighting those segments280
where significant differences were found.
Although results show non-negligible standard deviations, on average, the
simulated vagal contribution was consistent with physiological knowledge on
asymptomatic patients, decreasing at peak effort and increasing during post-
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Figure 8: Mean linear regression models adjusted to the estimation of vagal modulation at
peak effort and during post-exercise recovery, for symptomatic (orange) and asymptomatic
(black) patients. Dashed vertical lines delimit the analyzed periods and segments presenting
statistically significant differences between populations are noted (*p <0.05).
exercise recovery. However, significant alterations were noted on symptomatic285
patients, showing a mean positive slope at peak effort and a descending trend
during the second minute of recovery.
Thus, these findings provide further evidence for the role of autonomic im-
balance in the pathophysiology of BS. However, since this study is based on a
relatively small population of 44 BS patients, the moderately significant differ-290
ences found between analyzed groups should be interpreted carefully. Indeed,
the fact that corrected p-values would lead to non-significant results, indicates
that reliable physiological interpretations should be extracted by means of larger
clinical series. Moreover, the analyzed population presents a significant imbal-
ance between symptomatic and asymptomatic groups; although this is a com-295
mon scenario in BS, where symptoms refer to recovered SCD or syncope and,
thus, they are usually found in a small amount of patients. Likewise, most pre-
viously reported studies on BS autonomic function are based on clinical series of
similar, or even smaller, sizes [5, 6, 10, 7, 12, 8], as well as most works reporting
the identification of computational models are based on small populations.300
Thus, the implemented model-based approach provides the first time-varying
autonomic estimation in the context of BS, highlighting the relevance of exer-
cise testing in order to unmask significant changes in ANS modulation that may
not be captured at daytime, during a regular ECG examination. Indeed, this
17
altered autonomic cardiac system dynamics during post-exercise recovery, when305
vagal contribution is predominant, concurs with previous studies reporting an
increase in Brugada-like ECG changes induced during vagal stimulation [39],
as well as with the fact that most life-threatening cardiac arrhythmias in BS
occur at rest and during sleep, when parasympathetic activity is predominant
[40, 2]. Furthermore, the results confirm previous findings where symptomatic310
BS patients showed a higher vagal modulation [11, 10, 8] with respect to asymp-
tomatic patients, supporting the idea that increased vagal responses could be
related to a worse prognosis in Brugada syndrome.
4. Conclusions
Conventional methods have been proved insufficient for autonomic function315
analysis. Therefore, in this work, we propose an original model-based approach
to characterize ANS dynamics in response to exertion. It is based on a recur-
sively identified closed-loop model of the baroreflex and cardiovascular systems,
introducing: i) patient-specific model parameter recursive identifications and ii)
estimations of the time-varying sympathetic and parasympathetic modulations320
of the heart rate.
The model was evaluated with data from 44 BS patients, acquired during
exercise testing, to compare the autonomic function of symptomatic and asymp-
tomatic BS populations. Results show a close match between experimental and
simulated signals. Moreover, estimations of sympathetic and parasympathetic325
components were consistent with physiological knowledge, showing the feasibil-
ity of the model to reproduce realistic autonomic responses to exercise.
According to results, a significantly higher parasympathetic activity was ob-
served in symptomatic patients during exercise, providing further evidence for
the role of vagal contribution in BS prognosis. Moreover, during post-exercise330
recovery, parasympathetic modulation on symptomatic patients indicated an
autonomic imbalance. Thus, this original approach enables to unmask indica-
tors capturing cardiovascular and autonomic dynamics, never before studied in
18
BS, that may be useful for risk stratification. Indeed, we believe that a robust
BS risk stratification should be based on a combination of both classical electro-335
physiological features, but also on this kind of markers providing an improved
estimation of the autonomic activity.
More extensive evaluations including a wider range of parameters, a greater
population of patients, as well as the possibility of adjusting parameters based
on not only the HR, but also the blood pressure, should be performed in the340
future. Furthermore, the proposed model could be enriched by including a
representation of cardiorespiratory interactions [33].
Nevertheless, this paper presents the first model-based approach towards the
evaluation of the time-varying autonomic response to exertion in BS patients,
showing results that indicate trends of clinical relevance and, thus, provide a345
step forward towards the understanding of the disease.
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1TABLE I
CVS SUBMODEL PARAMETER VALUES.
Parameter Description Nominal value
Eao Aorta elastance (mmHg ml−1) 0.705
Evc Venae cavae elastance (mmHg ml−1) 0.011
Epa Pulmonary artery elastance (mmHg ml−1) 0.338
Epv Pulmonary vein elastance (mmHg ml−1) 0.006
ELV f Left ventricle free wall elastance (mmHg ml−1) 3.405
ERV f Right ventricle free wall elastance (mmHg ml−1) 0.653
Espt Septum elastance (mmHg ml−1) 48.754
Vd,ao Aorta dead volume (ml) 800
Vd,vc Venae cavae dead volume (ml) 2830
Vd,pa Pulmonary artery dead volume (ml) 160
Vd,pv Pulmonary vein dead volume (ml) 200
Vd,LV f Left ventricle free wall dead volume (ml) 5
Vd,RV f Right ventricle free wall dead volume (ml) 5
Vd,spt Septum dead volume (ml) 2
V0,pcd Pericardium end-diastolic volume (ml) 200
V0,LV f Left ventricle free wall end-diastolic volume (ml) 5
V0,RV f Right ventricle free wall end-diastolic volume (ml) 5
V0,spt Septum elastance end-diastolic volume (ml) 2
λpcd Pericardium end-diastolic exponent (ml−1) 0.030
λLV f Left ventricle free wall end-diastolic exponent (ml−1) 0.015
λRV f Right ventricle free wall end-diastolic exponent (ml−1) 0.015
λspt Septum end-diastolic exponent (ml−1) 0.435
P0,pcd Intrinsic pericardium pressure (mmHg) 0.500
P0,LV f Intrinsic left ventricle free wall pressure (mmHg) 1.275
P0,RV f Intrinsic right ventricle free wall pressure (mmHg) 1.200
P0,spt Instrinsic septum pressure (mmHg) 1.110
A Amplitude of Gaussian transition function (n.u.) 1
B Width of Gaussian transition function (n.u.) 80
C Center of Gaussian transition function (n.u.) 0.4
Rmt Mitral valve resistance (mmHg s ml−1) 0.001
Rav Aortic valve resistance (mmHg s ml−1) 0.011
Rtc Tricuspid valve resistance (mmHg s ml−1) 0.001
Rpu Pulmonary valve resistance (mmHg s ml−1) 0.004
Rpul Pulmonary circularion resistance (mmHg s ml−1) 0.143
Rsys Systemic circulation resistance (mmHg s ml−1) 1.050
Vtot Total blood volume (ml) 5500
Ppt Thoracic cavity pressure (mmHg) -4
2TABLE II
BRS SUBMODEL PARAMETER VALUES.
Parameter Description Nominal value
HR0 Intrinsic heart rate (Hz) 1.33
KB Baroreceptors gain (n.u.) 1
TB Baroreceptors time constant (s) 2
KV Gain for vagal heart rate modulation (n.u.) 1
TV Vagal time constant (s) 1.5
aV Normalization offset for vagal heart rate modulation (n.u.) 0
bV Normalization gain for vagal heart rate modulation (n.u.) 1
MV Normalization center for vagal heart rate modulation (n.u.) 100
λV Normalization exponent for vagal heart rate modulation (n.u.) -0.04
DV Vagal delay (s) 0.2
KS Gain for sympathetic heart rate modulation (n.u.) 1
TS Sympathetic time constant (s) 8
aS Normalization offset for sympathetic heart rate modulation (n.u.) 0
bS Normalization gain for sympathetic heart rate modulation (n.u.) 1
MS Normalization center for sympathetic heart rate modulation (n.u.) 100
λS Normalization exponent for sympathetic heart rate modulation (n.u.) 0.09
DS Sympathetic delay (s) 2
KR Gain for peripheral resistance modulation (n.u.) 1
TR Peripheral resistance time constant (s) 8
aR Normalization offset for peripheral resistance modulation (n.u.) 0
bR Normalization gain for peripheral resistance modulation (n.u.) 1
MR Normalization center for peripheral resistance modulation (n.u.) 100
λR Normalization exponent for peripheral resistance modulation (n.u.) 0.09
DR Peripheral resistance delay (s) 2
KV V Gain for venous volume modulation (n.u.) 1
TV V Venous volume time constant (s) 8
aV V Normalization offset for venous volume modulation (n.u.) 0
bV V Normalization gain for venous volume modulation(n.u.) 1
MV V Normalization center for venous volume modulation (n.u.) 100
λV V Normalization exponent for venous volume modulation (n.u.) 0.09
DV V Venous volume delay (s) 2
KE Gain for contractility/elastance modulation (n.u.) 1
TE Contractility time constant (s) 8
aE Normalization offset for contractility modulation (n.u.) 0
bE Normalization gain for contractility modulation (n.u.) 1
ME Normalization center for contractility modulation (n.u.) 100
λE Normalization exponent for contractility modulation (n.u.) 0.09
DE Contractility delay (s) 2
